CIRM Board Approves New Clinical Trial for ALS

CIRM Board Approves New Clinical Trial for ALS The governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $11.99 million to Cedars-Sinai to fund a clinical trial for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. Read more...